header
Image from OpenLibrary

Preparation and evaluation of certain gastroretentive drug delivery systems / Mina Mounir Louis ; Supervised Alia Abd Ellatif Badawy , Demiana Ibrahim Nesseem , Nevine Shawky Abdelmalak

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mina Mounir Louis , 2020Description: 195 P. : charts , facimiles ; 25cmOther title:
  • صياغة و تقييم لبعض أنظمة التوصيل الدوائية المحتفظة بالأمعاء [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics Summary: Among the different systems and devices used to control the drug delivery to the GIT, gastroretentive drug delivery systems have attracted much attention of academic researchers.Those systems are advantageous in case of drugs characterized by a narrow absorption window.They provide a prolonged intimate contact with the absorbing membrane; thereby, increasing efficacy. For a successful development of a gastroretentive drug delivery system, the selected dosage form must be able to reside for a time necessary to release the entire drug included before the normal physiology of the stomach can clear up the dosage form to the intestine. Several gastroretentive approaches are being designed and developed, including floating systems, high density systems, mucoadhesive systems, superporous hydrogel systems, expandable systems, and magnetic systems. In this study, we focused specifically on superporous hydrogel systems and effervescent floating mini-tablets formulations.These devices are excellent candidate materials for gastroretentive delivery of many drugs. Drotaverine hydrochloride (DRH) isa non-anticholinergic antispasmodic, which selectively inhibits phosphodiesterase IV.The plasma elimination half-life of DRH is about 7 h.The adult dose is about 40 to 80mg one to three times a day. Furthermore, the drug suffers from brief residence in the highly moving intestine during diarrhea which leads to poor bioavailability and frequent dosing. Therefore, the aim of this thesis is to prepare drotaverine hydrochloride as superporous hydrogel systems and effervescent floating mini-tablets formulae to provide prolonged release, reduce the frequency of dosing and improve patient compliance
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2020.Mi.P (Browse shelf(Opens below)) Not for loan 01010110082773000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2020.Mi.P (Browse shelf(Opens below)) 82773.CD Not for loan 01020110082773000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics

Among the different systems and devices used to control the drug delivery to the GIT, gastroretentive drug delivery systems have attracted much attention of academic researchers.Those systems are advantageous in case of drugs characterized by a narrow absorption window.They provide a prolonged intimate contact with the absorbing membrane; thereby, increasing efficacy. For a successful development of a gastroretentive drug delivery system, the selected dosage form must be able to reside for a time necessary to release the entire drug included before the normal physiology of the stomach can clear up the dosage form to the intestine. Several gastroretentive approaches are being designed and developed, including floating systems, high density systems, mucoadhesive systems, superporous hydrogel systems, expandable systems, and magnetic systems. In this study, we focused specifically on superporous hydrogel systems and effervescent floating mini-tablets formulations.These devices are excellent candidate materials for gastroretentive delivery of many drugs. Drotaverine hydrochloride (DRH) isa non-anticholinergic antispasmodic, which selectively inhibits phosphodiesterase IV.The plasma elimination half-life of DRH is about 7 h.The adult dose is about 40 to 80mg one to three times a day. Furthermore, the drug suffers from brief residence in the highly moving intestine during diarrhea which leads to poor bioavailability and frequent dosing. Therefore, the aim of this thesis is to prepare drotaverine hydrochloride as superporous hydrogel systems and effervescent floating mini-tablets formulae to provide prolonged release, reduce the frequency of dosing and improve patient compliance

Issued also as CD

There are no comments on this title.

to post a comment.